Preclinical studies and prospective clinical applications for bacteria-targeted imaging: the future is bright

被引：25

作者：

Heuker M. ^{[1
]}

Gomes A. ^{[1
]}

van Dijl J.M. ^{[1
]}

van Dam G.M. ^{[2
]}

Friedrich A.W. ^{[1
]}

Sinha B. ^{[1
]}

van Oosten M. ^{[1
]}

机构：

[1] Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen

[2] Department of Surgery, Division of Surgical Oncology, Nuclear Medicine and Molecular Imaging, Intensive Care, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen

来源：

Clinical and Translational Imaging | 2016年 / 4卷 / 4期

关键词：

Bacteria; Fluorescence; Imaging; Infection; Radioisotope; Tracer;

D O I：

10.1007/s40336-016-0190-y

中图分类号：

学科分类号：

摘要：

Bacterial infections are a frequently occurring and major complication in human healthcare, in particular due to the rapid increase of antimicrobial resistance and the emergence of pan-drug-resistant microbes. Current anatomical and functional imaging modalities are insufficiently capable of distinguishing sites of bacterial infection from sterile inflammation. Therefore, definitive diagnosis of an infection can often only be obtained by tissue biopsy and subsequent culture and, occasionally, a definite diagnosis even appears to be impossible. To accurately diagnose bacterial infections early, novel imaging modalities are urgently needed. In this regard, bacteria-targeted imaging is an attractive option due to its specificity. Here, different bacteria-targeted imaging approaches are reviewed, and their promising future perspectives are discussed. © 2016, The Author(s).

引用

页码：253 / 264

页数：11

共 86 条

[1]

Love C., Palestro C.J., Radionuclide imaging of infection, J Nucl Med Technol, 32, 2, pp. 47-57, (2004)

[2]

Laxminarayan R., Duse A., Wattal C., Zaidi A.K., Wertheim H.F., Sumpradit N., Et al., Antibiotic resistance—the need for global solutions, Lancet Infect Dis, 13, 12, pp. 1057-1098, (2013)

[3]

World Health Organization The evolving threat of antimicrobial resistance—options for action., (2016)

[4]

Parvizi J., Pawasarat I.M., Azzam K.A., Joshi A., Hansen E.N., Bozic K.J., Periprosthetic joint infection: the economic impact of methicillin-resistant infections, J Arthroplasty, 25, pp. 103-107, (2010)

[5]

Sabat A.J., Budimir A., Nashev D., Sa-Leao R., van Dijl J., Laurent F., Et al., Overview of molecular typing methods for outbreak detection and epidemiological surveillance, Euro Surveill, 18, 4, (2013)

[6]

Carek P.J., Dickerson L.M., Sack J.L., Diagnosis and management of osteomyelitis, Am Fam Physician, 63, 12, pp. 2413-2420, (2001)

[7]

Hatzenbuehler J., Pulling T.J., Diagnosis and management of osteomyelitis, Am Fam Physician, 84, 9, pp. 1027-1033, (2011)

[8]

Trampuz A., Zimmerli W., Diagnosis and treatment of infections associated with fracture-fixation devices, Injury, 37, pp. S59-S66, (2006)

[9]

van Oosten M., Hahn M., Crane L.M., Pleijhuis R.G., Francis K.P., van Dijl J.M., Et al., Targeted imaging of bacterial infections: advances, hurdles and hopes, FEMS Microbiol Rev, 39, 6, pp. 892-916, (2015)

[10]

Love C., Tomas M.B., Tronco G.G., Palestro C.J., FDG PET of infection and inflammation, Radiographics, 25, 5, pp. 1357-1368, (2005)

← 1 2 3 4 5 6 7 8 9 →